CorMedix, Inc. (CRMD)
7.42
+0.09
(+1.23%)
USD |
NASDAQ |
Apr 24, 16:00
7.425
0.00 (0.00%)
After-Hours: 20:00
CorMedix Market Cap : 586.55M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 153.59B |
| Altimmune, Inc. | 370.80M |
| Theravance Biopharma, Inc. | 847.57M |
| REGENXBIO, Inc. | 452.13M |
| Janux Therapeutics, Inc. | 913.08M |
Market Cap Related Metrics
| PE Ratio | 3.741 |
| PS Ratio | 1.910 |
| Price to Book Value | 1.447 |
| Price to Free Cash Flow | 3.446 |
| Price | 7.42 |
| Earnings Yield | 26.73% |
| Operating PE Ratio | 3.966 |
| Normalized PE Ratio | 3.726 |